NCT07385976 The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT07382713 Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07382479 NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery Status NOT_YET_RECRUITING Phase NA
NCT07371104 Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer Status RECRUITING Phase PHASE1
NCT07370818 To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07362147 Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life Status NOT_YET_RECRUITING Phase NA
NCT07361471 Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy Status RECRUITING Phase NA
NCT07355010 A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07340164 Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy Status RECRUITING Phase PHASE2
NCT07321730 Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer Status NOT_YET_RECRUITING Phase N/A
NCT07318558 A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) Status RECRUITING Phase PHASE3
NCT07318051 Sample Collection for Ongoing Research and Product Evaluation Study Status RECRUITING Phase N/A
NCT07303387 Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. Status RECRUITING Phase PHASE2
NCT07285941 Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment Status RECRUITING Phase PHASE2
NCT07278336 A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer Status RECRUITING Phase PHASE1
NCT07269574 Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance Status NOT_YET_RECRUITING Phase N/A
NCT07261683 Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer Status RECRUITING Phase PHASE2
NCT07239622 Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2